GENTILE, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 511
EU - Europa 374
AS - Asia 184
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.070
Nazione #
US - Stati Uniti d'America 509
UA - Ucraina 113
IE - Irlanda 94
IT - Italia 63
VN - Vietnam 56
HK - Hong Kong 50
SG - Singapore 50
FI - Finlandia 26
CN - Cina 23
DE - Germania 23
RU - Federazione Russa 20
SE - Svezia 11
GB - Regno Unito 5
AT - Austria 4
CH - Svizzera 4
NL - Olanda 4
CZ - Repubblica Ceca 3
CA - Canada 2
FR - Francia 2
TR - Turchia 2
EU - Europa 1
GR - Grecia 1
KR - Corea 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 1.070
Città #
Chandler 162
Dublin 92
Jacksonville 70
Dong Ket 56
Hong Kong 50
San Mateo 48
Singapore 40
Altamura 36
Medford 25
Princeton 25
Lawrence 22
Beijing 20
Perugia 20
Wilmington 16
Ann Arbor 8
Andover 7
Boardman 5
Norwalk 5
Helsinki 4
New York 4
Seattle 4
Des Moines 3
San Paolo di Civitate 3
Amsterdam 2
Ashburn 2
Brno 2
Den Haag 2
Huskvarna 2
Izmir 2
Moscow 2
Saint Petersburg 2
Auburn Hills 1
Belgrade 1
Council Bluffs 1
Houston 1
Lachine 1
Lappeenranta 1
London 1
Pakistan 1
Pittsburgh 1
Prato 1
Redwood City 1
Seoul 1
Shanghai 1
Tappahannock 1
Toronto 1
Vienna 1
Woodbridge 1
Totale 758
Nome #
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 69
Aliskiren versus ramipril in hypertension. 58
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 55
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 54
Angiotensin-converting enzyme inhibitors 54
Microalbuminuria and hypertension. 53
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 49
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 47
Optimal therapy in hypertensive subjects with diabetes mellitus 47
Blood pressure lowering in diabetic patients. 46
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi) 45
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 44
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 44
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 44
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 44
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 43
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 41
Comparative assessment of angiotensin receptor blockers in different clinical settings. 41
Telmisartan for the reduction of cardiovascular morbidity and mortality. 40
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 40
Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease 33
The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? 32
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 31
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 24
Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis 20
Totale 1.098
Categoria #
all - tutte 4.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 17 0 17 0 17 0 20 18 6 2
2020/2021210 0 17 0 17 63 1 19 1 17 1 18 56
2021/2022145 0 25 0 1 6 0 0 59 1 0 27 26
2022/2023410 25 102 4 44 37 41 0 20 118 2 17 0
2023/2024140 9 16 6 1 1 0 24 0 30 2 9 42
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.098